Dolphin 75 mg 3 ml 3 ampoules
0£
View analogsUsed for acute pain conditions, including renal colic, exacerbations of osteoarthritis and rheumatoid arthritis, acute back pain, acute gout attacks, acute injuries and fractures, and postoperative pain.
Form of Release: Ampoules
Product Brand: Delta Pharma
Product Categories: Painkillers, anti-inflammatory • Nonsteroidal anti-inflammatory drugs
Dolphin 75 mg 3 ml 3 ampoules
Composition:
Each 3 ml of solution contains:
Diclofenac sodium – 75 mg.
Excipients: Mannitol, propylene glycol, sodium bisulfite, benzyl alcohol, sodium hydroxide, water for injection.
Properties:
Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID) with pronounced antirheumatic, analgesic, anti-inflammatory, and antipyretic properties.
Indications:
Used for acute pain conditions, including renal colic, exacerbations of osteoarthritis and rheumatoid arthritis, acute back pain, acute gout attacks, acute injuries and fractures, and postoperative pain.
Method of administration:
For intramuscular use only. Other routes of administration are not allowed.
The injection should be administered deep into the gluteal muscle (outer upper quadrant). The duration of treatment is determined by the physician.
Dosage:
Adults – 1 ampoule once daily.
In cases of colic or other pain syndromes – 2 times per day (with an interval of 2–3 hours).
More than 2 injections per day are not permitted.
Maximum treatment duration – 2 days.
If continued treatment is necessary, it should be switched to oral tablets or rectal suppositories.
The total daily dose of diclofenac must not exceed 150 mg.
Contraindications:
Children
Hypersensitivity to diclofenac sodium, sodium bisulfite, or any excipients
Severe heart, liver, or kidney failure
Bradycardia, significant hypotension
Gastrointestinal bleeding
Pregnancy and breastfeeding
Patients with bronchial asthma, angioedema, urticaria, or acute rhinitis triggered by ibuprofen, aspirin, or other NSAIDs.
Precautions:
Discontinue administration if liver disorders develop.
Patients with cardiovascular conditions must be monitored during treatment.
In frail or elderly patients and individuals with low body weight, the minimum effective therapeutic dose should be used.
Prior to prescribing the medication, clinical examination is required for patients with:
Peptic ulcers
History of gastrointestinal bleeding
Liver and kidney disorders (including history)
Hypertension
In patients with bronchial asthma, hay fever, acute or chronic respiratory conditions, or nasal polyps, the drug may provoke asthma attacks. These conditions should be managed symptomatically.
Side effects:
In very rare cases, abscesses may occur at the injection site.
Other side effects include:
Headache, dizziness, vertigo
Tachycardia/bradycardia, hypertension, arrhythmia, heart failure
Abdominal pain, vomiting, cramps, flatulence, nausea, diarrhea, dyspepsia
Fluid retention, edema
Skin rash, angioedema
Injection site reactions.
Storage:
Store at a temperature not exceeding 30°C.
Keep out of reach of children.
Packaging:
Cardboard box contains 1 or 2 plastic trays with 3 ampoules each, and a paper leaflet.
Tags, Keywords:
Active Ingredients:
No comments yet. Be the first to write one.
Your comment will be published after moderation.
You’ll receive a notification to your email when someone replies.
Русский
English
عربي

